Trial Profile
Multicenter prospective single-group study of three-day regimen of oseltamivir (Tamiflu) for postexposure prophylaxis.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2020
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 19 Apr 2017 Status changed from not yet recruiting to recruiting.
- 03 Nov 2016 New trial record